Tower Research Capital (TRC)’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.5K | Buy |
6,938
+3,802
| +121% | +$35.4K | ﹤0.01% | 2748 |
|
|
2025
Q1 | $21.1K | Sell |
3,136
-5,472
| -64% | -$36.8K | ﹤0.01% | 2908 |
|
|
2024
Q4 | $91.4K | Buy |
8,608
+7,129
| +482% | +$75.7K | ﹤0.01% | 2189 |
|
|
2024
Q3 | $21.6K | Sell |
1,479
-523
| -26% | -$7.65K | ﹤0.01% | 3191 |
|
|
2024
Q2 | $24.2K | Buy |
2,002
+909
| +83% | +$11K | ﹤0.01% | 3651 |
|
|
2024
Q1 | $27K | Buy |
+1,093
| New | +$27K | ﹤0.01% | 2734 |
|
|
2023
Q3 | – | Sell |
-3,040
| Closed | -$24K | – | 6067 |
|
|
2023
Q2 | $24K | Buy |
3,040
+1,712
| +129% | +$13.5K | ﹤0.01% | 3197 |
|
|
2023
Q1 | $7K | Sell |
1,328
-1,030
| -44% | -$5.43K | ﹤0.01% | 4744 |
|
|
2022
Q4 | $5K | Buy |
+2,358
| New | +$5K | ﹤0.01% | 4873 |
|
|
2022
Q3 | – | Sell |
-2,489
| Closed | -$8K | – | 6261 |
|
|
2022
Q2 | $8K | Buy |
2,489
+2,357
| +1,786% | +$7.58K | ﹤0.01% | 4679 |
|
|
2022
Q1 | $1K | Sell |
132
-794
| -86% | -$6.02K | ﹤0.01% | 5807 |
|
|
2021
Q4 | $12K | Buy |
+926
| New | +$12K | ﹤0.01% | 4287 |
|
|
2021
Q3 | – | Sell |
-100
| Closed | -$2K | – | 5947 |
|
|
2021
Q2 | $2K | Sell |
100
-3,129
| -97% | -$62.6K | ﹤0.01% | 5047 |
|
|
2021
Q1 | $110K | Sell |
3,229
-1,841
| -36% | -$62.7K | ﹤0.01% | 2517 |
|
|
2020
Q4 | $49K | Buy |
+5,070
| New | +$49K | ﹤0.01% | 3142 |
|